Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Briacell Therapeutics Corp WT (BCTXW)

Briacell Therapeutics Corp WT (BCTXW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire - Fri Mar 24, 2023

/PRNewswire/ -- USA News Group - Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in...

BCTXW : 0.9499 (-1.05%)
ONC.TO : 1.43 (-0.69%)
BCT.TO : 2.95 (-0.67%)
ONCY : 1.0300 (-0.96%)
CTMX : 1.7300 (-1.70%)
BCTX : 2.15 (-0.57%)
RLAY : 6.11 (-1.61%)
HOLX : 75.10 (+0.24%)
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies Business Wire - Wed Nov 30, 2022

IPA (IMMUNOPRECISE ANTIBODIES LTD.) ( “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that BioStrand BV (“BioStrand”), an AI in silico discovery...

BCTX : 2.15 (-0.57%)
BCTXW : 0.9499 (-1.05%)
IPA : 1.2400 (-2.36%)
BCT.TO : 2.95 (-0.67%)
BriaCell Secures License for a Promising Novel Anti-Cancer Agent Globe Newswire - Thu Aug 4, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Aug. 04, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer Immunotherapy Globe Newswire - Tue Jul 5, 2022

Extended survival and tumor shrinkage in advanced breast cancer patients who matched the immunotherapy HLA types, lead to the development of BriaCell’s...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment Globe Newswire - Wed Jun 29, 2022

PHILADELPHIA and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal Globe Newswire - Fri Jun 24, 2022

Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in a leading peer-reviewed publication....

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment Globe Newswire - Wed May 18, 2022

PHILADELPHIA and VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy Globe Newswire - Wed Apr 13, 2022

U.S. Food and Drug Administration (FDA) has granted Fast Track status to BriaCell’s lead candidate, Bria-IMT™, for the treatment of metastatic breast...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell Presents Development Details of Bria-OTS™ Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Apr 12, 2022

Based on clinical data with Bria-IMT™, BriaCell has developed Bria-OTS™, an off-the-shelf (i.e. pre-manufactured) personalized immunotherapy.Bria-OTS™ will...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial Globe Newswire - Thu Apr 7, 2022

Bria-OTS™ would build on BriaCell’s existing clinical trial data with Bria-IMT™, treating each patient with the optimized pre-manufactured Bria-OTS™...

BCTXW : 0.9499 (-1.05%)
BCTX : 2.15 (-0.57%)
BCT.TO : 2.95 (-0.67%)

Barchart Exclusives

Stock Index Futures Slip as Middle East Tensions Weigh, Netflix Shares Plunge Barchart - 56 minutes ago
June S&P 500 E-Mini futures (ESM24) are down -0.37%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.53% this morning as worries of a conflict escalation in the Middle East weighed on sentiment following reports of Israel’s strikes on Iran. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot